Artelo Biosciences, Inc. Warrant
ARTLW
ARTLW was delisted on the 17th of June, 2024.
4 hedge funds and large institutions have $14K invested in Artelo Biosciences, Inc. Warrant in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
100% more capital invested
Capital invested by funds: $7K → $14K (+$7K)
33% more funds holding
Funds holding: 3 → 4 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.2K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $7K | – | – | – |
|
2
Verition Fund Management
Greenwich,
Connecticut
| $4K | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2K | +$2.2K | +16,708 | New |
|
|
AGM
4
Alpine Global Management
New York
| $1K | – | – | – |
|
ARTLW Hedge Fund Activity: Q2 2020 in Review
4 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q2 2020, worth a combined $14K — up 100% from $7K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ARTLW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.2K.
- 4 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q2 2020, up from 3 in Q1 2020.
- Funds reported $14K of Artelo Biosciences, Inc. Warrant stock for Q2 2020, up 100% quarter-over-quarter.
- 1 fund opened new Artelo Biosciences, Inc. Warrant positions in Q2 2020 and 0 closed out, a net change of +1 holder.
- The largest Artelo Biosciences, Inc. Warrant buyer in Q2 2020 was Susquehanna International Group, an estimated $2.2K added.
Based on aggregated 13F filings for Q2 2020.